Tuesday · October 6, 2026
Established

A Handful of Nuts a Day May Cut Hypertension Risk by Up to 26%

A meta-analysis of over 143,000 people found that eating more nuts, especially around a handful a day, was linked to meaningfully lower hypertension risk, likely via fiber-fed gut bacteria producing blood-pressure-lowering compounds.

A Handful of Nuts a Day May Cut Hypertension Risk by Up to 26%

If you have ever wondered whether something on your plate is quietly working on your blood vessels through your gut, a new meta-analysis (a statistical pooling of results from several existing studies to get one combined answer) gives one of the clearest signals yet, and it points to a food already sitting in most kitchens: nuts. Researchers combined data from more than 143,000 people across eight long-running studies and found that people who ate more nuts had a meaningfully lower chance of developing hypertension (high blood pressure), the condition that quietly drives strokes, heart attacks, and kidney disease. The size of the benefit tracked closely with how much people ate, and the study's authors point to a specific biological route behind it: the fiber in nuts feeding the bacteria that live in the gut.

Key Takeaways

  • A meta-analysis of 143,380 people across eight studies found the highest nut eaters had a 16% lower hypertension risk than the lowest, and each extra 28 grams a day (about a handful) was tied to a 20% lower risk.
  • The steepest benefit leveled off around 30 to 35 grams a day, a 26% lower risk than eating no nuts, matching existing dietary guidelines.
  • Researchers point to fiber fermenting into gut-bacteria-made short-chain fatty acids as a likely mechanism, alongside nitric oxide production and anti-inflammatory compounds.
  • This is observational data with moderate-to-high heterogeneity and no randomized trial yet, so it shows an association, not proof.

Meta-Analysis Links Higher Nut Intake to Lower Hypertension Risk

People who ate the most nuts had a 16% lower risk of developing hypertension than people who ate the least, according to a systematic review and dose-response meta-analysis published in the British Journal of Nutrition. Pooling eight prospective cohort studies covering 143,380 participants and 20,665 hypertension cases, researchers led by Michael Metoudi and senior author Dagfinn Aune, an epidemiologist at Imperial College London, calculated a summary relative risk (a ratio comparing how likely an outcome is in one group versus another) of 0.84 for the highest nut-intake group compared with the lowest (95% confidence interval: 0.77 to 0.91). Looking at risk per additional 28 grams of nuts eaten daily, about one standard serving or a handful, risk dropped by 20% (relative risk 0.80, 95% CI: 0.71 to 0.89). A closer look at the dose curve found the steepest gains up to roughly 30 to 35 grams a day, where risk was 26% lower than eating no nuts at all, after which the benefit leveled off.

Why This Matters for Anyone Managing Blood Pressure or Gut Health

Hypertension affects an estimated 1.4 billion adults worldwide and is a leading driver of strokes, heart failure, and chronic kidney disease. For readers who already suspect their blood pressure, or a condition like metabolic syndrome or cardiovascular disease, has something to do with their gut, this finding matters because nuts sit at the intersection of both: they are one of the few foods clinical bodies like the American Heart Association and the European Society of Cardiology already recommend for cardiovascular health, and this analysis adds hypertension specifically to that list. The effect was consistent whether the eight cohorts came from the United States, Europe, or Asia, and held up across men and women aged 18 to 87.

Eight Cohort Studies, One Pooled Analysis

The researchers searched PubMed and Embase through April 2026 for prospective cohort studies (long-term studies that track healthy people forward in time to see who later develops a condition) reporting adjusted risk estimates for nut intake and hypertension. Eight studies met the criteria: three from the United States, two from Europe (Spain and France), and three from Asia (South Korea, China, and Iran). To judge how strong the evidence was, the team applied World Cancer Research Fund (WCRF) grading criteria, a standardized system that weighs study design, consistency, dose-response, and biological plausibility together, and rated the likelihood that nuts causally reduce hypertension risk as probable, one step below the top grade of convincing. A sensitivity check that removed one study at a time kept the result stable, with the pooled risk ranging narrowly between 0.75 and 0.83 depending on which single study was excluded. The researchers also found no statistical signal of publication bias, meaning the result is unlikely to reflect only positive studies getting published (Egger's test p=0.10, Begg's test p=0.71).

The Gut Bacteria Link Behind the Blood Pressure Effect

The study's authors propose that fiber is doing much of the work, not directly, but through the gut microbiome (the community of trillions of bacteria living in the digestive tract). When gut bacteria ferment dietary fiber, they produce short-chain fatty acids (SCFAs), including propionate and butyrate, compounds the authors link directly to blood pressure reduction. This lines up with outside research: the HELIUS study, a large cohort spanning six ethnic groups, found that gut bacteria composition and fecal SCFA levels were measurably associated with blood pressure, and a 2021 review in Frontiers in Microbiology lays out how SCFAs act on receptors in the kidney, blood vessels, and nervous system to help regulate it. The American Heart Association has taken the connection seriously enough to issue a formal science advisory on hypertension and the gut microbiome, acknowledging gut bacteria and their metabolites as an emerging piece of the blood pressure puzzle. The study's authors also point to other plausible mechanisms working alongside fiber and SCFAs, including L-arginine (an amino acid that helps produce nitric oxide, a molecule that relaxes blood vessels) and anti-inflammatory plant compounds called polyphenols.

What the Study Can't Yet Prove

This is observational data, not a randomized controlled trial (RCT), so it shows a strong association rather than definitive proof that nuts themselves lower blood pressure; people who eat more nuts may also differ in other health habits the researchers could not fully account for. The pooled results also carried moderate to high statistical heterogeneity (a measure of how much individual study results disagreed with each other), ranging from 50% for the high-versus-low comparison to 75% for the dose-response analysis, and much of that disagreement traced back to a single South Korean cohort. Worth flagging directly: three of the four study authors are affiliated with Plant-Based Health Professionals UK, an organization that promotes plant-based diets including nut consumption; the paper states the organization had no role in the study's design, data collection, or analysis. None of the eight studies distinguished between salted and unsalted nuts, or between nut types like almonds versus walnuts, and none included populations from the Indian subcontinent or Africa, so it is not yet clear whether the effect generalizes to those groups or holds up specifically for salted nuts, given how well established salt's own role in raising blood pressure already is.

Where the Research Goes Next

The authors are calling for larger cohort studies that can separate out nut type and salt content, and for research that digs into specific nut metabolites like L-arginine to pin down which biological pathway matters most. Until then, the practical takeaway tracks with existing dietary guidance rather than overturning it: most European and North American guidelines already recommend around 28 to 30 grams of nuts a day, roughly the same handful-sized amount this analysis found associated with the biggest drop in hypertension risk.

Common Questions

Does this study prove nuts lower blood pressure? No. It is an observational meta-analysis of cohort studies, so it establishes a strong, dose-dependent association rather than direct proof of cause and effect; a randomized controlled trial would be needed to confirm it.

How many nuts should I eat based on this research? The strongest reduction in hypertension risk showed up around 30 to 35 grams a day, roughly one handful, which also matches existing dietary guidelines of about 28 to 30 grams daily.

Does the type of nut matter? The study could not say. None of the eight cohorts distinguished between specific nut types like almonds, walnuts, or peanuts, or between salted and unsalted nuts.

Why would gut bacteria affect blood pressure? Gut bacteria ferment fiber into short-chain fatty acids like propionate and butyrate, which travel through the bloodstream and act on receptors in the kidneys, blood vessels, and nervous system involved in regulating blood pressure.

Evidence Rating

ESTABLISHED — 90/100

Caveats

  • Observational cohort data, no RCT
  • Moderate-to-high heterogeneity across pooled studies (I2 50-75%)

Accepted-manuscript dose-response meta-analysis of 8 prospective cohort studies (n=143,380; 20,665 hypertension cases) in the British Journal of Nutrition. Summary RR 0.84 (0.77-0.91) highest vs lowest nut intake; RR 0.80 (0.71-0.89) per 28g/d; 26% lower risk at 30-35g/d vs none. WCRF criteria graded causality "probable." No evidence of publication bias (Egger’s p=0.10, Begg’s p=0.71). Gut-microbiome mechanism (fiber fermentation to short-chain fatty acids) is explicitly discussed by the study authors and corroborated by independent cohort and mechanistic literature.

References

  1. Michael Metoudi, Isabelle Sadler, Shireen Kassam, Dagfinn Aune (2026). Nut consumption and the risk of hypertension: a systematic review and dose response meta-analysis of prospective studies. British Journal of Nutrition. https://doi.org/10.1017/s0007114526108137
  2. Barbara J H Verhaar, Didier Collard, Andrei Prodan, et al. (2020). Associations between gut microbiota, faecal short-chain fatty acids, and blood pressure across ethnic groups: the HELIUS study. European Heart Journal. https://doi.org/10.1093/eurheartj/ehaa704
  3. Yeshun Wu, Hongqing Xu, Xiaoming Tu, Zhenyan Gao (2021). The Role of Short-Chain Fatty Acids of Gut Microbiota Origin in Hypertension. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2021.730809